Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment
Condition(s):Gestational Trophoblastic Neoplasias (GTN)Last Updated:February 29, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Gestational Trophoblastic Neoplasias (GTN)Last Updated:February 29, 2024Recruiting
Condition(s):Graft Vs Host Disease; Hematopoietic NeoplasmLast Updated:September 14, 2021Recruiting
Condition(s):Arthritis, RheumatoidLast Updated:October 6, 2017Completed
Condition(s):Psoriasis; MethotrexateLast Updated:July 21, 2021Unknown status
Condition(s):Pediatric Crohn’s DiseaseLast Updated:April 12, 2023Completed
Condition(s):Crohn’s DiseaseLast Updated:October 18, 2018Completed
Condition(s):DLBCLLast Updated:April 24, 2017Unknown status
Condition(s):Pharmacokinetics of Isavuconazole; Pharmacokinetics of Methotrexate; Pharmacokinetics of 7-hydroxymethotrexate; Healthy SubjectsLast Updated:June 24, 2013Completed
Condition(s):Low Dose Methotrexate in Severe Chronic AsthmaLast Updated:September 28, 2021Unknown status
Condition(s):Rheumatoid Arthritis; Insufficient Response to Methotrexate or LeflunomideLast Updated:July 12, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.